Big Gain For Avenue Therapeutics, Inc.

Tue, Sep 27, 2022 at 07:33 PM
Big Gain For Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc. (ATXI:NASDAQ) rocketted at $7.26, representing a gain of 106.3%. On Tue, Sep 27, 2022, ATXI:NASDAQ hit a New 2-Week High of $7.26. The stock got featured on our News Catalysts scanner on Fri, Sep 23, 2022 at 12:13 PM in the 'SPLIT' category. From Tue, Sep 13, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Tue, Sep 27, 2022 at $11.12 with a volume of 58M+.

About Avenue Therapeutics, Inc. (ATXI:NASDAQ)

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.